rawfin.tv
Ultragenyx Secures FDA Accelerated Approval for Gene Therapy GENGLYCOS
Marketsstocks🟠 Score 8AI Generated

Ultragenyx Secures FDA Accelerated Approval for Gene Therapy GENGLYCOS

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Ultragenyx Pharmaceutical Inc. received accelerated FDA approval for GENGLYCOS, its first gene therapy targeting GSDIa. This milestone marks a significant advancement for the company and the gene therapy sector.

biotechnologygene-therapyFDA-approvalpharmaceuticalsUltragenyx

Related Articles

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

stocks
Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

stocks
Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

stocks
Barclays Workforce Trimmed 5% as Bank Increases Focus on AI

Barclays Workforce Trimmed 5% as Bank Increases Focus on AI

stocks